Quick Answer
Adagene Inc. reported Total Revenue of $103.2 thousand for fiscal year 2024.
Adagene Inc. — Key Financials by Year
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Total Revenue | $103.2K -99.4% |
$18.11M +94.9% |
$9.29M -8.7% |
$10.18M +1351.7% |
$700.9K +46.0% |
$480.0K -68.2% |
| Revenue (ASC 606) | $103.2K -99.4% |
$18.11M +94.9% |
$9.29M -8.7% |
$10.18M +1351.7% |
$700.9K +46.0% |
$480.0K -68.2% |
| Net Income | -$33.42M -76.4% |
-$18.95M +76.3% |
-$79.97M -9.3% |
-$73.18M -72.6% |
-$42.40M -158.0% |
-$16.43M -7.6% |
| Diluted EPS | -$0.59 -68.6% |
-$0.35 +76.4% |
-$1.48 -1.4% |
-$1.46 +45.3% |
-$2.67 -142.7% |
-$1.10 -17.0% |
| Total Assets | $89.27M -22.9% |
$115.73M -24.1% |
$152.40M -19.6% |
$189.51M +124.9% |
$84.26M -20.4% |
$105.89M |
| Cash and Equivalents | $85.19M -22.5% |
$109.93M -23.5% |
$143.76M -17.6% |
$174.39M +132.1% |
$75.15M -18.8% |
$92.53M |
| Long-Term Debt | $417.3K -96.9% |
$13.54M -4.3% |
$14.15M +372.8% |
$2.99M +0.9% |
$2.97M +95.6% |
$1.52M |
| Stockholders Equity | $50.52M -28.4% |
$70.56M -15.1% |
$83.09M -46.9% |
$156.56M +275.1% |
-$89.39M -56.8% |
-$57.01M -39.0% |
| R&D Expense | $28.78M -21.4% |
$36.64M -55.0% |
$81.34M +19.4% |
$68.10M +103.1% |
$33.54M +106.9% |
$16.21M +0.8% |
| Operating Income | -$35.95M -51.6% |
-$23.72M +71.7% |
-$83.92M -16.0% |
-$72.36M -67.7% |
-$43.15M -125.1% |
-$19.17M -10.6% |
| Shares Outstanding | 58.89M +6.8% |
55.15M +2.0% |
54.07M -1.0% |
54.60M +228.8% |
16.60M +9.3% |
15.19M |
- Adagene Inc. reported Total Revenue of $103.2 thousand for fiscal year 2024.
- Adagene Inc. showed a decrease of -99.4% in Total Revenue compared to the prior fiscal year.
- Adagene Inc. reported Revenue (ASC 606) of $103.2 thousand for fiscal year 2024.
- Adagene Inc. showed a decrease of -99.4% in Revenue (ASC 606) compared to the prior fiscal year.
- Adagene Inc. reported Net Income of -$33.42 million for fiscal year 2024.
- Adagene Inc. showed a decrease of -76.4% in Net Income compared to the prior fiscal year.
- Adagene Inc. reported Diluted EPS of $0.59 per share (loss) for fiscal year 2024.
- Adagene Inc. showed a decrease of -68.6% in Diluted EPS compared to the prior fiscal year.
- Adagene Inc. reported Total Assets of $89.27 million for fiscal year 2024.
- Adagene Inc. showed a decrease of -22.9% in Total Assets compared to the prior fiscal year.
- Adagene Inc. reported Cash and Equivalents of $85.19 million for fiscal year 2024.
- Adagene Inc. showed a decrease of -22.5% in Cash and Equivalents compared to the prior fiscal year.
- Adagene Inc. reported Long-Term Debt of $417.3 thousand for fiscal year 2024.
- Adagene Inc. showed a decrease of -96.9% in Long-Term Debt compared to the prior fiscal year.
- Adagene Inc. reported Stockholders Equity of $50.52 million for fiscal year 2024.
- Adagene Inc. showed a decrease of -28.4% in Stockholders Equity compared to the prior fiscal year.
- Adagene Inc. reported R&D Expense of $28.78 million for fiscal year 2024.
- Adagene Inc. showed a decrease of -21.4% in R&D Expense compared to the prior fiscal year.
- Adagene Inc. reported Operating Income of -$35.95 million for fiscal year 2024.
- Adagene Inc. showed a decrease of -51.6% in Operating Income compared to the prior fiscal year.
- Adagene Inc. reported Shares Outstanding of 58.89 million shares for fiscal year 2024.
- Adagene Inc. showed an increase of +6.8% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: